Updated UK guidance for finerenone introduces new treatment for HF patients
This new guidance provides doctors in the UK with another important treatment option for heart failure (HF).
Therapy Area
FDA approval of mFLUSIVA highlights Moderna’s position in mRNA market
Evotec and Odyssey collaborate on AI-enabled R&D
Pfizer seeks label expansion for Litfulo after double Phase III NSV win
Novartis and Takeda drugs gain rare blood cancer routine use on NHS
Bayer’s heart failure drug bound for NHS on NICE recommendation
Women’s health attracted record equity in 2025 as companies share capital
EAN 2026: Bocunebart’s promise as migraine preventive in treatment-refractory patients
